BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction. [electronic resource]
Producer: 20210329Description: 41-50.e8 p. digitalISSN:- 1938-0666
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- genetics
- Chemotherapy, Adjuvant
- Datasets as Topic
- Disease-Free Survival
- Down-Regulation
- Female
- Follow-Up Studies
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Kaplan-Meier Estimate
- MAP Kinase Signaling System -- genetics
- Mastectomy
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local -- epidemiology
- Oligonucleotide Array Sequence Analysis
- Prognosis
- Proto-Oncogene Proteins B-raf -- metabolism
- Receptor, ErbB-2 -- analysis
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Risk Assessment -- methods
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.